News

PMLive24m
Regeneron’s Lynozyfic granted FDA accelerated approval to treat multiple myeloma
Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...
PMLive26m
Alzheimer’s disease – the silent pandemic and the positive impact of AI
Alzheimer’s disease has rightly been characterised as a ‘silent pandemic’, with the number of Americans over 65 who are ...